Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China; College of Pharmacy, Jining Medical University, Rizhao 276826, People's Republic of China.
Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
Bioorg Chem. 2020 Oct;103:104226. doi: 10.1016/j.bioorg.2020.104226. Epub 2020 Aug 26.
Cephafortunoids A-D (1-4), four new compounds, together with ten known ones (5-14), were isolated from the branches and leaves of Cephalotaxus fortunei var. alpina. 1 and 2 represent the first examples of Cephalotaxus troponoid diterpenoids featured an intact C skeleton with CH-17 migrating to C-15 and C-13 respectively. 3 and 4 are novel cephalotane-type diterpenoids with an epoxy ring between C-12 and C-13. The structures of isolated compounds were established by extensive spectroscopic methods, electronic circular dichroism (ECD) calculations, and comparison with reported data. In in vitro bioassays, all isolated compounds were evaluated for their cytotoxic activities against human promyelocytic leukemia cells (HL-60), human acute monocytic leukemia cells (THP-1), human breast cancer cells (MDA-MB-231), and human prostate cancer cells (PC-3). 5-9 exhibited prominent cytotoxicity against HL-60 and THP-1 with GI values of 0.27-5.48 and 0.48-7.54 μM, respectively. 5-8 showed evident cytotoxicity against MDA-MB-231 and PC-3 with IC values of 1.96-10.66 and 2.72-13.99 μM, severally. 6 with an IC value of 2.72 ± 0.35 μM displayed stronger cytotoxicity against PC-3 than the positive control etoposide. The structure-activity relationship of these compounds and plausible biogenetic pathways for 1-4 were discussed.
从 Cephalotaxus fortunei var. alpina 的枝叶中分离得到了四个新化合物 Cephafortunoids A-D(1-4),以及十个已知化合物(5-14)。1 和 2 代表了 Cephalotaxus troponoid 二萜类化合物的第一个例子,它们具有完整的 C 骨架,CH-17 分别迁移到 C-15 和 C-13。3 和 4 是新型的 cephalotane 型二萜类化合物,在 C-12 和 C-13 之间具有环氧环。通过广泛的光谱方法、电子圆二色性(ECD)计算和与报道数据的比较,确定了分离化合物的结构。在体外生物测定中,所有分离得到的化合物均针对人早幼粒细胞白血病细胞(HL-60)、人急性单核细胞白血病细胞(THP-1)、人乳腺癌细胞(MDA-MB-231)和人前列腺癌细胞(PC-3)进行了细胞毒性活性评价。5-9 对 HL-60 和 THP-1 表现出显著的细胞毒性,GI 值分别为 0.27-5.48 和 0.48-7.54 μM。5-8 对 MDA-MB-231 和 PC-3 表现出明显的细胞毒性,IC 值分别为 1.96-10.66 和 2.72-13.99 μM。6 的 IC 值为 2.72±0.35 μM,对 PC-3 的细胞毒性强于阳性对照依托泊苷。讨论了这些化合物的结构-活性关系以及 1-4 的可能生物合成途径。